Work

Bortezomib, Melphalan and Low Dose TBI Conditioning for Patients Undergoing Autologous Stem Cell Transplantation for Multiple Myeloma

Year: 2016

Type: article

Study design: Clinical Trial

Source: Blood

DOI: 10.1182/blood.v128.22.2267.2267

Authors: Francis K Buadi, Morie A. Gertz, Betsy R. Laplant, Alese Halvorson, Martha Q. Lacy, Suzanne R. Hayman, David Dingli, Prashant Kapoor, Wilson I Gonsalves, Teresa Miceli, Eva Brandes, Scott L Stafford, James A Martenson, William J Hogan, Shaji K. Kumar

Institution: Mayo Clinic

Language: English

Topic: Multiple Myeloma Research and Treatments

Subfield: Hematology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2612385690

FWCI:

Cites:

Cited by:

Related to: 10